177947-67-0

Basic information

• Product Name: 1-Pyrrolidinecarboxylic acid, 3-(phenylmethoxy)-, 1,1-dimethylethyl ester, (3R)-
• CAS NO: 177947-67-0
• Molecular Formula: C16H23NO3
• Molecular Weight: 277.364
• Mol File: 177947-67-0.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 1-Pyrrolidinecarboxylic acid, 3-(phenylmethoxy)-, 1,1-dimethylethyl ester, (3R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pyrrolidinecarboxylic acid, 3-(phenylmethoxy)-, 1,1-dimethylethyl ester, (3R)-(177947-67-0)
• EPA Substance Registry System: 1-Pyrrolidinecarboxylic acid, 3-(phenylmethoxy)-, 1,1-dimethylethyl ester, (3R)-(177947-67-0)

Safety Data

• Hazardous Substances Data: 177947-67-0(Hazardous Substances Data)

Usage

Physical form

White crystalline solid

Use

Used in the synthesis of various pharmaceuticals and agrochemicals

Importance

An important intermediate in the production of organic compounds, known for its versatility in chemical reactions

Applications

Various applications in the fields of medicine, agriculture, and chemical research

Production

Used in the production of various chemical products in the chemical industry

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 109431-87-0 (R)-tert-butyl 3-hydroxypyrrolidine-1-carboxylate 
• 100-44-7 benzyl chloride 
• 101385-90-4 (R)-N-benzyl-3-hydroxypyrrolidine 
• 100-39-0 benzyl bromide 

Downstream Products

• 927819-90-7 (R)-3-(benzyloxy)pyrrolidine hydrochloride 
• 900513-88-4 (1R,2R)-2-[(R)-3-(benzyloxy)pyrrolidin-1-yl]cyclohexanol 
• 795281-89-9 trans-2-[(3R)-3-benzyloxy-1-pyrrolidinyl]cyclohexanol 
• 1204419-18-0 (R)-(3-(benzyloxy)pyrrolidin-1-yl)(3,5-dinitrophenyl)methanone 
• 177947-68-1 (3R)-4-<3-(benzyloxy)pyrrolidin-1-yl>butanal dimethyl acetal 
• 177948-70-8 (3R)-N(H)-3-(benzyloxy)pyrrolidine 

Relevant articles and documents

A fang chanfu law compound and its preparation method, pharmaceutical composition and use thereof

The invention relates to a new compound for conversion of auricular fibrillation, as shown in the general formula i in the specification (n in the formula is equal to 0 to 4), or pharmaceutically acceptable salt thereof. The invention also provides a novel compound used as a preventive medicine or therapeutic drug for atrial fibrillation, a preparation method and a pharmaceutical composition containing the compound.

Anti-infective compounds

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.

PROCESS FOR PRODUCTION OF BENZYLOXYPYRROLIDINE DERIVATIVE, AND PROCESS FOR PRODUCTION OF HYDROCHLORIDE SALT POWDER OF OPTICALLY ACTIVE BENZYLOXYPYRROLIDINE DERIVATIVE

Provided are: a process for production of a benzyloxypyrrolidine derivative in high yield and safety, and a process for production of a hydrochloride powder of a benzyloxypyrrolidine derivative in high yield and safety; the process for production of a benzyloxypyrrolidine derivative expressed by the general formula (2) [Chemical formula 2], in reacting a pyrrolidinol derivative represented by the general formula (1) [Chemical formula 1 with a benzyl halide derivative in the presence of an alkali metal hydroxide, wherein the reaction is carried out in either of the following conditions A or B; condition A: an aprotic polar solvent, and condition B: an aliphatic ether solvent containing a phase transfer catalyst: